KPV is a tripeptide (Lys-Pro-Val) derived from alpha-Melanocyte Stimulating Hormone (alpha-MSH). It exhibits potent anti-inflammatory, antimicrobial, and immunomodulatory properties, primarily by inhibiting NF-κB activation pathways. While its role in directly extending healthspan is not well-established, these actions could theoretically mitigate chronic inflammation, a known driver of aging and various age-related pathologies.
Verdict
Experimental peptide, anti-inflammatory; healthspan relevance speculative, safety data limited.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
High
EVIDENCE GRADE
C
MONTHLY COST
$30 - $100
Protocol
- Topical application in creams or gels 1-2 times daily for localized inflammatory conditions.
- Subcutaneous injection protocols are highly variable and primarily used in research settings.
Flags
- Regulatory status as a research chemical means quality and purity are not guaranteed.
- Long-term systemic safety profile in humans for healthspan applications is largely unknown.
- Potential for immune modulation, requiring careful consideration in individuals with autoimmune conditions.